How Is Industrial Biotechnology Being Used to Produce Biodegradable Plastics and Biofuels, and Why Hasn’t It Replaced Petrochemicals on a Large Scale Yet

You’re holding a plastic water bottle. It feels exactly like every other plastic bottle you’ve ever touched — rigid, lightweight, transparent. But this one was made by bacteria. Living microorganisms consumed sugar, processed it through their metabolic pathways, and excreted the polymer chains that eventually became the material in your hands. And when you’re done with it, if you put it in the right conditions, those same kinds of biological processes will break it back down into water and carbon dioxide within months rather than centuries.

This isn’t a fantasy. It’s happening right now, in fermentation tanks in facilities across the United States, Europe, and Asia. Industrial biotechnology — the application of biological systems, living organisms, and biological processes to industrial manufacturing — has made remarkable strides in producing materials and fuels that could, in principle, replace the petrochemical products that have dominated our economy for over a century. The science is real. The products exist. Companies are selling them.

So why are you still filling your car with gasoline refined from crude oil? Why is the overwhelming majority of plastic still made from fossil fuel feedstocks? Why, despite decades of research and billions of dollars of investment, has industrial biotechnology not yet replaced petrochemicals at the scale that its most passionate advocates promised? And more importantly — what would it actually take to get there?

That’s the question this article is going to answer honestly, thoroughly, and without the kind of breathless optimism that has characterized too much of the public conversation about this technology. We’re going to cover the genuine achievements of industrial biotechnology, the real and stubborn obstacles that have prevented it from scaling, the lessons buried in both the successes and the failures, and what the realistic road forward actually looks like for a technology that genuinely matters for the future of our planet.

What Industrial Biotechnology Actually Means and Why It Matters

Let’s make sure we’re on solid ground conceptually before we go deeper, because “industrial biotechnology” is one of those terms that gets used in ways that range from precise to meaninglessly broad. In its most specific and useful sense, industrial biotechnology refers to the use of enzymes, microorganisms, and biological systems to manufacture products at industrial scale. It’s also called white biotechnology, to distinguish it from red biotechnology, which covers medical and pharmaceutical applications, and green biotechnology, which covers agricultural applications.

The scope of what industrial biotechnology can produce is genuinely staggering once you start mapping it out. We’re talking about fuels, plastics, fibers, solvents, adhesives, lubricants, surfactants, flavors, fragrances, vitamins, amino acids, organic acids, and specialty chemicals of every description — essentially the full range of products that the petrochemical industry currently derives from crude oil and natural gas. The microorganisms and enzymes involved in industrial biotechnology are extraordinarily diverse. Bacteria like Escherichia coli and Bacillus subtilis are workhorses of the field, easy to grow quickly and highly amenable to genetic engineering. Yeast — particularly Saccharomyces cerevisiae, the same organism that makes bread rise and wine ferment — is another foundational platform organism with decades of industrial deployment behind it.

Fungi, microalgae, cyanobacteria, and even engineered mammalian cells play important roles in specific applications. What makes these organisms useful for industrial production is their metabolic machinery — the vast, intricate networks of chemical reactions that cells use to process nutrients into the molecules they need to survive and reproduce. These networks are, in a very real sense, the most sophisticated chemical engineering systems that have ever existed. They operate at ambient temperature, at atmospheric pressure, in water, with extraordinary selectivity and efficiency, and they’ve been refined by four billion years of evolution.

By engineering these metabolic pathways — either through classical strain development involving cycles of mutation and selection, or through modern synthetic biology tools including CRISPR-based genome editing, computational metabolic modeling, and DNA synthesis — scientists can redirect cellular metabolism toward producing specific target molecules in commercially useful quantities. The cell becomes a tiny chemical factory, running on biological feedstocks and producing outputs that industrial chemistry would otherwise derive from petroleum through processes requiring high temperatures, high pressures, toxic catalysts, and vast quantities of energy.

The environmental appeal of this approach is obvious. If we can make the same products we currently make from oil using renewable biological feedstocks, we can potentially break the link between industrial production and the extraction and combustion of ancient carbon. We can reduce greenhouse gas emissions, reduce dependence on a finite and geopolitically concentrated resource, and potentially create products that return gracefully to biological cycles at the end of their useful life rather than persisting in the environment for geological timescales. That’s the vision. Understanding why it’s harder to realize than it sounds requires going deep into the science, the engineering, and the economics — and that’s exactly where we’re going.

The Story of Bioplastics: How Biology Learned to Make Plastic

The idea that microorganisms could make plastics is not new — it dates back to the 1920s when a French microbiologist named Maurice Lemoigne first identified that certain bacteria accumulated a polymer called polyhydroxybutyrate, or PHB, inside their cells as an energy storage mechanism. PHB has thermoplastic properties — it can be melted and molded like conventional plastic. The bacteria making it were essentially doing for free, as a normal part of their physiology, something that the petrochemical industry achieves through energy-intensive chemical synthesis requiring petroleum feedstocks and harsh reaction conditions.

That discovery sat largely dormant for decades, waiting for the convergence of environmental concern, rising oil prices, and advances in biotechnology that would eventually make it commercially interesting. That convergence began in earnest in the 1980s, when the first serious commercial development efforts began, and has accelerated dramatically since the 2000s, driven by growing awareness of plastic pollution, increasingly ambitious climate policy, and the rapid maturation of synthetic biology tools that make engineering industrial microorganisms far faster and more precise than was previously possible.

Today, there are several distinct families of biologically produced plastics with different properties, different production methods, and different positions in the market. Understanding the differences between them is important for making sense of the industry’s trajectory and its challenges.

Polyhydroxyalkanoates — PHAs — represent the most purely biological class of bioplastics. They’re produced directly inside bacteria as intracellular granules, accumulated under conditions of nutrient stress when the carbon source is abundant but other nutrients like nitrogen or phosphorus are limited. Under these conditions, bacteria essentially gorge themselves on carbon, converting the excess into PHA as an energy reserve — the microbial equivalent of building up fat deposits. The bacteria can be harvested when they’re packed full of PHA granules, and the polymer is extracted and purified for use.

PHA is remarkable because it’s genuinely thermoplastic — it can be melted and processed using the same equipment used for conventional petroleum-based plastics — and because it’s genuinely biodegradable under a wide range of environmental conditions, including soil, compost, and — critically — marine environments. PHAs can be broken down by naturally occurring enzymes produced by microorganisms widely distributed in natural environments, in timeframes that are genuinely meaningful compared to the geological timescales over which conventional plastics persist. This marine biodegradability is particularly significant given the catastrophic scale of plastic pollution in ocean environments.

The PHA family is actually quite diverse — different chain lengths and different monomer compositions produce PHAs with different physical properties, from stiff and brittle materials resembling conventional polypropylene to flexible, elastomeric materials with properties reminiscent of rubber. This chemical diversity means that PHA can potentially be tailored for a wide range of applications, though producing specific PHA compositions requires specific genetic engineering of the producing microorganism and adds complexity to the production process.

Polylactic acid — PLA — takes a different route to bio-based plastic. Rather than being produced directly by microorganisms, PLA is made in a two-step process. First, microorganisms ferment sugars into lactic acid through a well-established fermentation process. Then, the lactic acid is chemically polymerized — through a series of chemical reactions — into PLA polymer. This hybrid biological-chemical approach means that the fermentation step benefits from the selectivity and efficiency of biology, while the polymerization step uses established chemical manufacturing infrastructure.

PLA is already commercially significant at a scale that PHA has not yet reached. NatureWorks, based in the United States, operates a large commercial PLA facility and has been selling PLA commercially since the early 2000s. Global PLA production capacity is measured in hundreds of thousands of tons per year, and the material is used in food packaging, disposable cups and cutlery, agricultural films, textile fibers, and three-dimensional printing filament. PLA has genuinely replaced conventional plastic in some of these applications, particularly in single-use food service items in markets with strong environmental preferences.

PLA’s biodegradability story is more complicated and more nuanced than PHA’s, and understanding this nuance is important because it has significant implications for PLA’s genuine environmental value and for the policy frameworks built around it. PLA degrades efficiently in industrial composting conditions — at temperatures above 55 degrees Celsius, maintained for several weeks, in the presence of specific microorganisms that produce PLA-degrading enzymes.

Under these conditions, PLA breaks down into lactic acid and carbon dioxide on timescales of weeks to months. In home composting conditions, which rarely reach the necessary temperatures, PLA degrades very slowly — often over years rather than months. In marine environments, it’s even more persistent. And in landfills, which are anaerobic environments that don’t support the aerobic microbial activity needed for PLA degradation, it may persist for decades.

This gap between the ideal end-of-life scenario and the real-world disposal reality of PLA has been a source of legitimate criticism. “Compostable” labeling on PLA products can mislead consumers into believing the material will naturally biodegrade in any environment, when in fact it requires specific industrial infrastructure that is severely underdeveloped in most countries. This is not an argument against PLA — it’s an argument for honesty about what “compostable” means and for investment in the industrial composting infrastructure that would make PLA’s environmental claims actually realized in practice.

The Third Major Bioplastic Category: Drop-In Bio-Based Polymers

Beyond PHA and PLA, there’s a third important category of bio-based plastics that deserves attention: bio-based versions of conventional petroleum-derived polymers. These materials are chemically identical to their petroleum-based counterparts — the same polymer chains, the same physical properties, the same processing requirements — but they’re made from biological feedstocks rather than petroleum.

Bio-based polyethylene, made by fermenting sugars to ethanol and then chemically dehydrating the ethanol to ethylene, which is then polymerized in the same way as petroleum-derived polyethylene, is the most commercially significant example. Brazilian company Braskem has been producing bio-based polyethylene from sugarcane ethanol at commercial scale for over a decade. The material is used in plastic bottles, bags, and various packaging applications, and carries marketing appeal as a “green” plastic for brands concerned about their sustainability profiles.

The environmental advantage of bio-based polyethylene versus petroleum-based polyethylene is primarily in carbon footprint — using renewable sugarcane rather than petroleum as the carbon source reduces lifecycle greenhouse gas emissions — rather than in end-of-life biodegradability. Bio-based polyethylene is chemically identical to petroleum-based polyethylene, so it has the same persistence in the environment and the same biodegradability — essentially none, on human timescales. It’s also recyclable through the same recycling streams as conventional polyethylene, which is an advantage over PHA and PLA, which contaminate conventional plastic recycling if mixed in.

This category illustrates an important strategic choice in the bio-based plastics space: whether to prioritize the use of renewable feedstocks and the associated carbon footprint benefits, or to prioritize end-of-life biodegradability. These properties don’t necessarily come together in the same material, and different applications may warrant different priorities. A disposable coffee cup used once and then sent to an industrial composting facility might be best served by PLA. A durable plastic container used for years and then recycled might be best served by bio-based but non-biodegradable polyethylene. A product likely to end up in marine environments — fishing gear, agricultural mulch film — might be best served by genuinely marine-biodegradable PHA.

The Feedstock Question: What Do Bioplastics and Biofuels Actually Eat?

One of the most fundamental challenges facing bioplastics — and biofuels, which face exactly the same issue — is the feedstock question. The microorganisms producing these materials need carbon to work with, and the choice of carbon source has enormous implications for the economics, the sustainability, the scalability, and the political acceptability of the whole enterprise. Getting the feedstock question right is arguably as important as getting the biology and engineering right.

First-generation bioplastics and biofuels used food crops as their primary feedstock — corn starch in the United States, sugarcane in Brazil, sugar beet in Europe, and various other starch or sugar crops in different regions. These crops were fermented to produce the sugars that microorganisms then converted into target molecules. This approach worked technically — you could make large quantities of ethanol, lactic acid, or other bio-based chemicals from food crops — but it immediately generated what became known as the food-versus-fuel debate.

Using agricultural land, water, fertilizers, pesticides, and farm labor to grow crops for industrial feedstocks rather than food raised legitimate ethical questions in a world where food security is already fragile for hundreds of millions of people. When food prices rose sharply in 2007 and 2008, partly coinciding with the rapid expansion of US corn ethanol production, the political backlash against first-generation biofuels was fierce and damaged the broader bio-based products narrative in ways that lingered for years. The criticism was in some cases overstated — the relationship between biofuel production and food prices is complex and contested among agricultural economists — but it contained enough truth to be damaging.

Beyond the food competition issue, the agricultural input requirements for first-generation feedstocks were themselves substantial. Growing corn for bioethanol or for PLA production requires land, freshwater, nitrogen and phosphorus fertilizers, pesticides and herbicides, and farm machinery running on diesel fuel. Life cycle analyses that accounted for all these upstream inputs often showed significantly smaller environmental benefits than initial enthusiasm had suggested. Some analyses of corn ethanol showed carbon footprints surprisingly close to gasoline when the full agricultural footprint was included. The field was forced to develop much more sophisticated life cycle assessment methodologies to honestly evaluate what the bio-based advantage actually was.

Second-generation approaches tried to address the food competition and sustainability concerns by using non-food biomass as feedstocks. Agricultural residues — the stalks, leaves, and husks left in the field after food crops are harvested — represent an enormous and currently underutilized carbon resource. Corn stover, wheat straw, sugarcane bagasse, rice husks, and similar materials are available in quantities that dwarf what is currently used for industrial biotechnology feedstocks. Forestry residues from logging operations, paper mill waste streams, municipal yard waste, and dedicated non-food energy crops like switchgrass and miscanthus grown on marginal agricultural land represent additional feedstock sources that don’t compete directly with food production.

The challenge with these lignocellulosic feedstocks — the term referring to the complex mixture of cellulose, hemicellulose, and lignin that makes up plant cell walls — is that getting fermentable sugars out of them is considerably harder than fermenting simple sugars or corn starch. Plant cell walls are designed by evolution to be structurally robust and resistant to degradation — that’s the whole point of a cell wall.

Breaking down the lignocellulosic matrix to release the cellulose sugars for fermentation requires a combination of physical, chemical, and enzymatic pretreatment steps that are energy-intensive, expensive, and technically complex. Getting this preprocessing step economically efficient enough to make the overall process competitive has been one of the central technical challenges of the cellulosic biofuel and bioplastic field for decades.

Third-generation approaches take the feedstock question in an even more radical direction, looking toward carbon dioxide captured from the atmosphere or from industrial point sources, methane from agricultural waste and landfills, and even carbon monoxide from industrial off-gases as feedstocks. Some microorganisms can grow using these one-carbon molecules as their sole carbon and energy source — autotrophic bacteria that fix carbon the way plants do, but without requiring agricultural land or arable soil. If these organisms can be engineered to produce useful chemicals and materials while growing on waste carbon streams, the result would be biomanufacturing that is genuinely decoupled from agricultural land use and potentially genuinely carbon-negative.

The science supporting third-generation approaches is real and advancing rapidly. Several companies are demonstrating commercial-scale production using industrial waste gases as feedstocks. But the engineering challenges of growing microorganisms on gaseous feedstocks at industrial scale — maintaining adequate gas-liquid mass transfer, managing the heat generated by exothermic reactions, preventing contamination in large open systems, harvesting and processing dilute microbial biomass — are substantial and are still being actively worked through.

Biofuels: The Promise, the Progress, and the Painful Reality

Biofuels represent one of the most extensively developed, most heavily invested, most politically controversial, and most thoroughly scrutinized applications of industrial biotechnology. Their trajectory — from enormous early promise through painful commercial struggles to a more nuanced current reality — offers some of the most instructive lessons available for understanding why replacing petrochemicals at scale is so difficult.

The first wave of biofuel development achieved genuine commercial scale. The United States built a corn ethanol industry that now produces tens of billions of gallons annually, blended into gasoline at a 10 percent concentration under the federal Renewable Fuel Standard. Brazil built a sugarcane ethanol industry that has achieved genuine cost competitiveness with gasoline without subsidy in the Brazilian market — a remarkable achievement representing decades of sustained agricultural breeding, agronomic optimization, and process engineering improvement. European biodiesel from vegetable oils and animal fats reached significant commercial scale supported by blending mandates.

But first-generation ethanol has significant technical limitations that constrain its ability to truly displace petroleum fuels. Its energy density is roughly two-thirds that of gasoline — a gallon of ethanol contains fewer BTUs than a gallon of gasoline, which means you get fewer miles per gallon burning ethanol-blended fuel. Ethanol is hygroscopic — it absorbs water from the atmosphere — which causes phase separation and corrosion problems in distribution infrastructure designed for petroleum products and limits the concentration at which it can be blended without requiring modified engines. At the 10 percent blending level used in most US gasoline, ethanol doesn’t actually displace all that much total petroleum, and at higher blending levels, widespread engine compatibility issues emerge.

Advanced biofuels — producing drop-in replacements for petroleum fuels, molecules chemically similar or identical to the hydrocarbons in gasoline, diesel, and jet fuel, that could flow through existing pipelines and power existing engines without modification — became the major focus of second-generation biofuel development starting in the mid-2000s. The vision was compelling: use lignocellulosic biomass instead of food crops, produce real hydrocarbons instead of ethanol, and slot seamlessly into the existing petroleum infrastructure. The US Department of Energy invested billions of dollars in this vision. Dozens of venture-backed startups pursued it. Major oil companies entered partnerships with biofuel technology developers.

The results were genuinely sobering. Company after company discovered that producing hydrocarbon drop-in biofuels at economic competitiveness with petroleum was far harder than the initial science suggested it would be. The metabolic pathways that microorganisms use to produce hydrocarbons — isoprenoid pathways, fatty acid pathways — are less efficient in terms of carbon conversion and energy yield than the pathways producing ethanol or organic acids.

The fermentation yields were lower. The products were often toxic to the producing microorganisms at concentrations well below what would be commercially useful, requiring engineering solutions to improve tolerance. Downstream extraction and purification of hydrocarbon products from fermentation broth was energetically expensive. And the capital costs of building demonstration and commercial-scale facilities were consistently higher than projected.

Several high-profile companies that raised hundreds of millions of dollars pursuing advanced drop-in biofuels ultimately went bankrupt, pivoted to other products, or merged with competitors. The sector experienced a sustained period of investment drought and reputation damage in the early-to-mid 2010s. The lesson was not that advanced biofuels are impossible — it was that the technology was further from commercial readiness than the excitement of early laboratory results had suggested, and that the timelines and capital requirements for getting to commercial scale had been systematically underestimated.

The current advanced biofuel landscape in 2026 is more targeted and more realistic than the broad ambitions of a decade ago. Sustainable aviation fuel — SAF — has emerged as the most important near-term market for advanced biofuels, for reasons that make compelling strategic sense. Aviation cannot be electrified with current or near-term battery technology because the energy density required for long-haul flight is far beyond what batteries can provide.

The aviation sector faces increasing regulatory and market pressure to decarbonize. And aviation fuel commands a premium price compared to road transport fuels that improves the economics of more expensive bio-based production. Several commercial SAF production facilities are operating or under construction, and the policy environment in both the United States and Europe is creating genuine market demand.

The Economics Problem: Why Biology Struggles to Beat Petroleum

To understand why industrial biotechnology hasn’t replaced petrochemicals at scale, you have to understand the economics of the competition it faces with clear-eyed honesty — and that competition is extraordinarily tough in ways that require real explanation rather than vague references to “cost challenges.”

Petroleum is, in many respects, the most remarkable industrial feedstock that human civilization has ever had access to. It represents hundreds of millions of years of biological carbon, compressed and chemically transformed by geological processes into an extraordinarily energy-dense, chemically versatile liquid that happens to be globally abundant and extractable at remarkably low cost in favorable geological settings. At the marginal cost of production — which in the world’s lowest-cost oil fields can be as little as a few dollars per barrel — petroleum is simply cheap in a way that makes biological alternatives very hard to compete with on pure cost grounds.

The petroleum refining industry is one of the most capital-efficient and operationally optimized industries in the history of manufacturing. The major refineries operating today have been running for decades, have long since recovered their construction capital costs, and operate with extraordinary efficiency — waste heat streams are captured and reused, byproduct streams are processed and sold, operational procedures have been refined through millions of hours of operation. The industrial chemistry that converts crude oil into the full range of petroleum products — fuels, lubricants, solvents, polymer feedstocks — is deeply understood and highly optimized.

A new biomanufacturing facility, by contrast, carries full capital costs that need to be recovered from product revenue over the facility’s operating lifetime. The fermentation equipment — the large stainless steel vessels, the aeration and agitation systems, the instrumentation and control systems — the feedstock preprocessing infrastructure, the heat exchange and utility systems, the downstream purification equipment — all of this represents hundreds of millions or even billions of dollars of capital investment for a commercial-scale facility. At commodity chemical scales, where product prices are thin margins above the cost of production, this capital burden is a severe competitive disadvantage relative to long-depreciated petroleum facilities.

The raw material costs compound this disadvantage. Petroleum, even at prices well above historical averages, represents an incredibly concentrated and energy-rich carbon source. Agricultural feedstocks — sugars, starches, lignocellulosic biomass — are more expensive per unit of carbon than petroleum derivatives, partly because they carry the full costs of agricultural production including land, labor, water, and inputs, and partly because they’re more chemically dilute, requiring more processing to get them into a form usable for fermentation. The result is a raw material cost disadvantage that the efficiency of the biological conversion process must overcome — and often cannot fully overcome.

Energy costs add another layer to the economic challenge. Fermentation is an energy-intensive process — not because the fermentation reaction itself requires much energy input, but because the peripheral systems do. Large fermentation vessels require agitation to keep contents mixed and to transfer oxygen to the microbial cells. They generate heat that must be removed. The downstream processing steps — centrifugation, filtration, chromatography, evaporation, drying — all consume energy. In a world where energy costs are low and stable, these costs are manageable. In a world where energy is expensive and carbon-priced, they become a more significant fraction of total production cost.

The Scaling Challenge: From Laboratory Promise to Industrial Reality

Even when industrial biotechnology achieves genuinely exciting results at laboratory scale, the path from those results to commercial-scale production is far longer, more expensive, and more technically uncertain than the initial results suggest. This scaling challenge is one of the most consistently underappreciated aspects of the field, and understanding it is essential for calibrating realistic expectations about how quickly bio-based production can displace petroleum.

Fermentation processes that work beautifully in a five-liter laboratory vessel routinely encounter serious and sometimes unexpected problems when scaled to five-thousand-liter or fifty-thousand-liter industrial fermenters. The reasons are rooted in fundamental physics. In a small vessel, mixing can be rapid and nearly uniform — nutrients, oxygen, and the microbial cells stay reasonably well-distributed throughout the liquid, temperature is easy to control precisely, and the chemical environment experienced by each cell is relatively consistent. In a large industrial vessel, achieving perfect mixing is physically impossible. The power input required to agitate a large volume of liquid grows faster than the volume itself, meaning that the energy cost of mixing rises dramatically with scale.

The inevitable consequence is the development of gradients within large fermenters — spatial variations in oxygen concentration, pH, temperature, substrate concentration, and product concentration. In regions where oxygen is depleted, aerobic microorganisms experience oxygen stress that reduces their productivity and can alter their metabolism in ways that change the product mix. In regions where substrate — the carbon source being fed to the cells — accumulates between mixing events, cells may experience feast-and-famine cycles that trigger unproductive metabolic responses. These gradient effects need to be characterized, understood, and managed for each specific fermentation process at each scale of operation, and this work is time-consuming and expensive.

The biological performance of the microbial strain itself can change as scale increases, for reasons beyond just the mixing dynamics. Microorganisms that have been optimized for performance in a laboratory environment may behave differently in an industrial environment where the composition of the nutrient medium, the quality of the water, the presence of trace contaminants in feedstocks, and the specific dynamics of large-scale fermentation create conditions subtly different from anything the strain experienced during its laboratory development. Sometimes these differences are minor and manageable. Sometimes they require significant additional strain engineering to address.

The economics of scale-up are equally daunting. Moving from laboratory proof-of-concept to the first commercial facility typically requires progression through multiple intermediate stages — bench scale, pilot scale, demonstration scale, commercial scale — each requiring its own capital investment and its own process development work. A pilot facility might cost tens of millions of dollars. A demonstration facility might cost one hundred million dollars. A commercial-scale facility might cost five hundred million dollars or more. Getting through this progression requires sustained investment over periods of five to fifteen years, during which no commercial revenue is being generated and the technology risk remains substantial.

What Has Actually Worked: Celebrating the Real Successes

In the midst of an honest assessment of why industrial biotechnology hasn’t achieved its most ambitious goals, it’s critically important to recognize the genuine commercial successes that do exist — applications where bio-based production has achieved real competitive viability and is making meaningful differences in markets and environmental footprints. These successes are instructive not just because they’re worth celebrating, but because they illuminate the conditions under which industrial biotechnology can win.

Industrial enzymes are probably the most commercially successful and simultaneously the least publicly recognized application of industrial biotechnology. The enzymes used in laundry detergent — proteases that break down protein stains, lipases that tackle grease, amylases that address starch-based soils, cellulases that help refresh fabric — are produced through large-scale microbial fermentation and represent a global market worth billions of dollars annually. The food processing industry uses microbial enzymes for everything from cheese making to corn syrup production to bread baking. The textile industry uses them for fabric finishing. The paper industry uses them for pulp processing.

These markets work for industrial biotechnology because the specific selectivity of biological catalysts provides performance advantages that chemical alternatives can’t match, and because the scale of production has been sufficient to drive unit costs down to commercially competitive levels. The enzyme industry succeeded because it found applications where biology’s unique capabilities created genuine value that customers were willing to pay for — not just because bio-based production was environmentally better, but because it was functionally better.

The 1,3-propanediol story represents one of the most instructive specific examples of successful industrial biotechnology deployment. DuPont and Genencourt collaborated to develop a fermentation process for producing 1,3-propanediol — a chemical with specific properties that make it valuable as a monomer for polyester fiber production — using metabolically engineered E. coli.

The fermentation process proved genuinely competitive with petroleum-based synthesis of 1,3-propanediol because the specific chemistry involved was particularly well-suited to biological production, and DuPont built a commercial facility in Tennessee that has been operating successfully for years. The bio-based 1,3-propanediol goes into Sorona fiber, used in carpeting and performance apparel, where it carries both performance and sustainability advantages. This success happened because the combination of feedstock economics, biological conversion efficiency, product value, and market positioning aligned in a way that made the business case genuinely compelling.

Brazilian sugarcane ethanol stands as perhaps the most impressive large-scale success story in the bio-based fuels space. The Brazilian bioethanol industry, built over decades through sustained government support combined with continuous private investment in agricultural and process optimization, has achieved genuine cost competitiveness with petroleum gasoline without the need for ongoing subsidies.

The sugarcane crop has been continuously improved through breeding and agronomic development. The fermentation and distillation processes have been refined to extraordinary efficiency. The bagasse — the fibrous residue remaining after juice extraction — provides most of the energy needed to run the ethanol plant, dramatically improving the energy and carbon balance of the process. And the scale of production — tens of billions of liters per year — has driven unit costs down to genuinely competitive levels.

The Role of Synthetic Biology in Accelerating Progress

The emergence of synthetic biology as a mature engineering discipline has given industrial biotechnology a set of tools that are genuinely transforming what’s possible, at a pace that would have seemed remarkable even a decade ago. The ability to precisely design and construct metabolic pathways in microorganisms, to introduce genes from multiple organisms into a single host to create entirely new biosynthetic capabilities, and to use sophisticated computational tools to predict and optimize metabolic outcomes — these capabilities have compressed the development timeline for new bio-based production processes in ways that are beginning to show up in commercial results.

CRISPR-based genome editing has dramatically accelerated microbial strain development. What once required years of classical strain improvement through iterative cycles of random mutagenesis and screening can now be accomplished in months through targeted, precise genetic modifications. Researchers can make exactly the changes they want to a microorganism’s genome — inserting new pathways, deleting competing pathways, fine-tuning the expression of specific enzymes — without the uncertainty and off-target effects of random mutagenesis. The precision and speed of CRISPR-based engineering mean that the optimization of industrial microorganisms is becoming faster and more rational than ever before.

Metabolic flux analysis and computational modeling of cellular metabolism have given researchers the ability to predict how changes to a cell’s metabolic network will affect its productivity before making any genetic modifications. By building mathematical models of the metabolic network — capturing the reactions, the enzymes, the regulatory interactions, and the thermodynamic constraints — researchers can simulate the effects of engineering interventions in silico and identify the modifications most likely to improve production. This reduces the experimental effort required for strain development and allows researchers to explore a much larger space of possible interventions than would be feasible through purely experimental approaches.

The convergence of synthetic biology with machine learning and artificial intelligence is creating particularly exciting opportunities for accelerating industrial biotechnology development. Machine learning models trained on large datasets of genetic sequence information, protein structure data, enzyme activity measurements, and fermentation performance data can identify nonobvious patterns and opportunities for improvement that human researchers would be unlikely to find through intuition or manual analysis. Protein engineering guided by AI — designing novel enzyme variants with improved activity, stability, or selectivity — is already producing results that are being deployed in commercial industrial biotechnology applications.

Carbon Pricing and Policy: The Economic Environment That Changes Everything

Here is a fundamental truth about why industrial biotechnology hasn’t replaced petrochemicals at scale that goes beyond the science and engineering: petroleum products are systematically underpriced relative to their true social cost. The price you pay at the gasoline pump or for a bag of petroleum-based plastic packaging reflects the cost of extracting, refining, and distributing the petroleum, plus whatever taxes governments choose to levy.

It does not reflect the cost of the carbon dioxide released when those products are burned or degrade. It does not reflect the cost of plastic pollution to marine ecosystems. It does not reflect the long-term costs of climate change that future generations will bear. If petroleum products were priced to include these externalities — to internalize the full social cost of their production and use — the competitive economics of bio-based alternatives would look dramatically more favorable than they currently do.

This is not a novel insight. Environmental economists have been making this argument for decades, and the policy instrument designed to address it — carbon pricing, through either a carbon tax or a cap-and-trade emissions trading system — is well understood theoretically and has been implemented in various forms in numerous jurisdictions. The EU Emissions Trading System, British Columbia’s carbon tax, and various other carbon pricing mechanisms have all demonstrated that carbon pricing is administratively feasible and that it does shift investment and production decisions toward lower-carbon alternatives.

But globally, carbon pricing remains either absent or set at price levels too low to substantially change the petroleum-versus-bio-based competitive equation in commodity markets. The political economy of carbon pricing is extremely difficult — fossil fuel industries have enormous economic and political power, the costs of carbon pricing are concentrated and immediate while the benefits are diffuse and long-term, and carbon pricing is easily characterized as a tax increase in ways that mobilize political opposition. Even in jurisdictions where carbon pricing exists, the price levels are generally well below what economic analyses suggest would be needed to drive the full decarbonization of industrial production.

Extended producer responsibility legislation — policies that make manufacturers financially responsible for the end-of-life management of their products, including collection, sorting, and disposal or recycling — represents another policy instrument that could substantially shift the competitive economics of bioplastics versus conventional plastics. If conventional plastic producers had to internalize the cost of managing plastic waste, including the fraction that escapes waste management systems and ends up in the environment, the cost advantage of conventional plastics would narrow substantially. Bioplastics that offer genuine end-of-life advantages — certified industrial compostability or marine biodegradability — would become more competitive in a regulatory environment that made producers responsible for end-of-life outcomes.

Infrastructure Lock-In: The Trillion-Dollar Barrier

There’s a systems-level challenge facing industrial biotechnology that rarely receives the attention it deserves in discussions about scaling bio-based products: the profound lock-in created by existing petroleum infrastructure. The petroleum economy is not merely a collection of chemical processes that could be replaced one by one with bio-based alternatives. It is an enormously complex, tightly integrated, globally interconnected physical infrastructure that took a century to build, has been continuously optimized, and has shaped the entire physical architecture of modern industrial economies.

Petroleum refineries are not just facilities for processing crude oil — they are integrated chemical plants that produce dozens of different products simultaneously, each optimized for specific markets, with complex interconnections between processing units that allow efficiency improvements impossible in simpler facilities. The pipeline networks, storage terminals, and distribution systems that move petroleum products from refineries to end users represent trillions of dollars of infrastructure investment optimized specifically for handling petroleum products with their specific physical and chemical properties.

Bio-based products that aren’t chemically identical to petroleum products — which includes PHA, PLA, and most other bioplastics — cannot simply plug into this existing infrastructure. They require different storage conditions, different transportation considerations, different processing at conversion facilities, and different end-of-life infrastructure than what the petroleum economy has built. Even biofuels that are designed to be used in existing engines at low blend levels face infrastructure challenges when blending above certain concentrations.

The cost of adapting or replacing existing infrastructure for bio-based alternatives is massive and represents a barrier that is additional to and largely independent of the production cost challenges already discussed. Even if bio-based production became cost-competitive with petroleum production tomorrow — which it won’t, but hypothetically — the transition to a bio-based economy would still require enormous investments in new infrastructure and would still face resistance from existing infrastructure owners whose assets would be stranded.

The Biodegradability Complexity: What “Biodegradable” Actually Means

One of the most important things to understand about biodegradable bioplastics — and one of the areas where public understanding is most significantly disconnected from scientific reality — is that biodegradability is not a simple, uniform property. It’s a complex characteristic that depends critically on the specific material, the specific microbial community present in the degradation environment, the temperature and moisture conditions, the presence of oxygen, and other factors. Getting this nuance right matters enormously for both honest environmental assessment and effective public policy.

Some materials marketed as biodegradable or compostable degrade efficiently only under very specific industrial composting conditions — high temperature, controlled moisture, specific microbial community — that don’t exist in most of the environments where plastic waste actually ends up. If these materials escape into the environment through littering, through waste management failures, or through windblown dispersal from waste facilities, they may persist for years or decades — not the centuries of conventional plastic, but long enough to cause meaningful harm to wildlife and ecosystems that mistake them for food or become entangled in them.

The PHA bioplastics represent the most genuinely biodegradable category of commercial bioplastics. The enzymes that break down PHA — PHA depolymerases — are produced by a wide range of bacteria and fungi that are distributed throughout soil and aquatic environments globally. When PHA-based materials end up in soil or water, the native microbial communities colonize them and begin breaking them down, ultimately mineralizing them to carbon dioxide and water. This process is not instantaneous — the rate depends on temperature, microbial community composition, and the surface area of the material — but it occurs naturally, without industrial intervention, in timeframes of months to a few years rather than centuries.

PLA occupies a more complicated middle ground. The lactic acid in PLA can be metabolized by a wide range of microorganisms, but the polymer itself is resistant to degradation at low temperatures because its crystalline structure limits enzyme accessibility. Industrial composting conditions — temperatures above 55°C maintained for several weeks — denature the crystalline structure, making the polymer accessible to degrading enzymes and enabling complete degradation. In home compost or in soil at ambient temperatures, PLA degradation is much slower. This temperature dependence is a fundamental material property of PLA that cannot be changed without altering the polymer’s structure in ways that affect its physical properties.

Algae: The Perpetually Promising and Persistently Challenging Feedstock

No treatment of industrial biotechnology’s attempts to replace petrochemicals would be complete without an honest reckoning with algae — the photosynthetic microorganisms that have been described, with persistent optimism, as the perfect bio-based feedstock for at least three decades. The promise of algae has captivated researchers, investors, and policymakers since at least the 1970s, and understanding both why the promise is real and why it has been so difficult to realize is instructive for the broader story of industrial biotechnology.

The theoretical advantages of microalgae as a feedstock are genuinely compelling. Algae perform photosynthesis, using sunlight and carbon dioxide as their primary inputs — which means, in principle, that an algae-based production system could operate without agricultural land and without the sugar or starch feedstocks that drive first-generation bioplastic and biofuel economics. Algae grow rapidly — many species can double their biomass multiple times per day under favorable conditions — and they can accumulate extraordinary concentrations of lipids, proteins, or carbohydrates depending on the strain and cultivation conditions. Some algae strains can accumulate lipid content exceeding 50 percent of their dry weight under nitrogen starvation — an oil content that dwarfs any terrestrial oilseed crop.

Algae can also be grown in brackish water or seawater, eliminating competition with freshwater agriculture and enabling cultivation on land unsuitable for conventional agriculture. And they capture carbon dioxide as they grow, offering the prospect of coupling algae cultivation with industrial carbon capture — growing algae on the CO2 exhaust from power plants or industrial facilities and converting the captured carbon into valuable products.

The practical challenges of realizing this promise at commercial scale have proven persistent and severe. Light penetration into dense algae cultures limits productivity — as the culture becomes denser, cells shade each other, reducing the average light availability per cell and capping the productivity achievable in a given volume. Getting adequate carbon dioxide dissolved into the liquid culture — required for rapid growth — is technically challenging at scale and energy-intensive. Maintaining axenic or near-axenic conditions in large open pond systems is essentially impossible — contaminating organisms inevitably colonize the culture, competing with the target algae strain and often outcompeting it over time.

Despite massive investments by the US Department of Energy’s Aquatic Species Program (running from 1978 to 1996), by major oil companies including ExxonMobil and Chevron in the late 2000s and 2010s, and by dozens of venture-backed startups, algae-based biofuel has not achieved economic competitiveness with petroleum fuel at any meaningful commercial scale. This doesn’t mean it never will — the biology and the engineering continue to improve, and specific applications may find viable niches — but the gap between potential and practical reality has proven far larger and more persistent than decades of optimistic projections suggested.

Using Waste Streams: The Most Promising Near-Term Direction

One of the most practically promising and arguably most underappreciated directions for industrial biotechnology is the use of existing waste streams as feedstocks. Rather than growing dedicated crops for industrial fermentation — with all the land use, water, and agricultural input requirements that entails — using the organic waste that human industrial society generates in enormous quantities sidesteps the food-versus-fuel problem and simultaneously addresses a waste management challenge.

The scale of available waste feedstocks is genuinely impressive. Agriculture generates enormous quantities of crop residues — corn stover, wheat straw, rice straw, sugarcane bagasse, cotton gin waste — that are currently managed through field burning, incorporation into soil, or low-value disposal. The food processing industry generates massive quantities of organic byproduct streams — cheese whey, corn steep liquor, vegetable processing waste, brewery and distillery residues — that are costly to manage and potentially valuable as fermentation feedstocks. Municipal solid waste contains substantial organic fractions — food waste, paper, yard waste — that represent a significant carbon resource currently sent to landfills or incineration.

LanzaTech’s gas fermentation technology represents one of the most commercially successful examples of waste-stream industrial biotechnology. LanzaTech uses bacteria that naturally grow on carbon monoxide as their energy and carbon source — organisms isolated from environments rich in carbon monoxide, such as volcanic vents and coal mine effluents.

The company has engineered these bacteria to produce ethanol, and has built commercial facilities at steel mills in China and elsewhere that capture the carbon monoxide-rich off-gases from steel production and convert them into fuel-grade ethanol. This approach turns a waste gas stream that would otherwise be flared or burned at low efficiency into a valuable chemical product, improving the carbon footprint of steel production while generating revenue from a previously wasted resource.

What Will It Actually Take to Scale Up?

Being honest about what needs to happen for industrial biotechnology to genuinely displace petrochemicals at commercial scale requires confronting several converging requirements, none of which is trivial, and all of which need to progress simultaneously for the transition to actually happen at meaningful speed and scale.

The microbial production economics need to improve substantially, and they will — but the improvement will be gradual rather than sudden. Continued advances in synthetic biology tools, metabolic engineering, and fermentation process development will drive incremental improvements in microbial productivity, yield, and product concentration. Better feedstock preprocessing technologies will reduce the cost of accessing lignocellulosic and waste-based carbon sources. Larger production facilities and accumulated operational experience will drive down capital and operating costs through learning curve effects and economies of scale. None of these improvements will happen overnight, but the trajectory is positive and the pace is accelerating.

Policy environments in major economies need to correctly price the externalities of petrochemical production — both the carbon footprint and the end-of-life environmental costs of plastic waste. This is a political challenge that requires sustained public engagement, credible advocacy from the scientific and industrial communities, and the political will to implement policies that have concentrated costs and diffuse benefits. Extended producer responsibility for plastic waste, meaningful carbon pricing, and production incentives for bio-based materials all have roles to play, and the evidence from jurisdictions that have implemented such policies suggests they do shift industrial economics in the direction needed.

Industrial composting and other end-of-life infrastructure for bioplastics needs to be built at scale to realize the environmental benefits that bioplastics can offer in principle. This infrastructure development requires both public investment — because waste management infrastructure is largely a public responsibility — and clear regulatory frameworks that define what compostable means and ensure that materials labeled as compostable actually reach composting facilities rather than landfills.

The Competitive Landscape: Where Bio-Based Products Actually Win Today

While commodity chemical and fuel markets remain extremely difficult for bio-based production, industrial biotechnology is finding genuine commercial traction in market segments where its specific advantages are most relevant and most valued. Mapping these winning segments is important for understanding where investment and development effort are likely to have the greatest near-term impact.

High-value specialty chemicals represent the strongest current success territory. Products requiring high chemical purity, specific stereochemistry, or precise structural features that are difficult to achieve through petroleum chemistry — active pharmaceutical ingredients, flavor and fragrance compounds, specialty monomers for high-performance polymers, chiral building blocks for asymmetric synthesis — are applications where biological catalysis provides genuine performance advantages that justify premium pricing. In these markets, the higher production costs of biomanufacturing are offset by the value of the specific properties that biology uniquely enables.

The personal care and cosmetics market is becoming an increasingly important destination for bio-based specialty chemicals, driven by consumer preference for “natural” ingredients and by the genuine performance advantages that bio-based surfactants, emollients, and active ingredients offer in certain formulations. Rhamnolipid biosurfactants, squalene from microbial fermentation, hyaluronic acid produced by bacterial fermentation, and various other bio-based specialty ingredients are achieving commercial success in premium personal care formulations.

A Realistic Vision for the Coming Decade

What does an honest, evidence-based assessment of industrial biotechnology’s trajectory look like over the next ten years? Not a utopian vision where biology has displaced petroleum — that’s not happening in a decade — but a realistic picture of where the technology is genuinely headed and what it will actually achieve.

PHAs will grow substantially from their current niche position. Improvements in fermentation yield and downstream processing efficiency are making PHA production more economical, and growing regulatory pressure on single-use plastics in marine-adjacent applications — fishing gear, aquaculture equipment, agricultural mulch film, personal care product packaging — is creating market pull for genuinely marine-biodegradable materials that PHA uniquely provides. We should expect commercial PHA production to grow from its current tens of thousands of tons per year to hundreds of thousands of tons by the mid-2030s, while remaining far short of the scale of conventional plastic production.

Sustainable aviation fuel will be the fastest-growing segment of advanced biofuels, driven by regulatory mandates in Europe and by voluntary corporate commitments from airlines seeking to manage their climate exposure. Multiple commercial SAF production pathways — including alcohol-to-jet routes, Fischer-Tropsch routes from gasified biomass, and hydroprocessed esters and fatty acids — will scale up, supported by the price premium that aviation fuel commands over road transport fuel and by the policy environment creating demand certainty for SAF producers.

Conclusion

The question at the heart of this article — why hasn’t industrial biotechnology replaced petrochemicals at large scale — doesn’t yield to a single, simple answer. It yields to many answers operating simultaneously and reinforcing each other: the extraordinary economic and infrastructure strength of the incumbent petroleum system; the genuine and stubborn technical challenges of scaling biological processes to the volumes and price points needed to compete in commodity markets; the policy failure to price petroleum’s environmental externalities in ways that would level the competitive playing field; the infrastructure lock-in that makes transitions slow even when technologies improve; and the fundamental complexity of matching bio-based product properties with realistic end-of-life pathways and the infrastructure needed to realize those pathways in practice.

What gives genuine reason for optimism is not that these obstacles are small — they’re not — but that they’re all being worked on simultaneously, by an increasingly sophisticated and well-resourced scientific and industrial community, in an increasingly favorable policy environment as the consequences of continued dependence on petrochemicals become clearer and more politically salient. The science of industrial biotechnology is genuinely advancing faster than at any previous point in its history. The tools available for engineering industrial microorganisms have never been more powerful. The understanding of fermentation processes and scale-up challenges has never been deeper.

Industrial biotechnology will not replace petrochemicals overnight, and anyone who tells you it will is either not being fully honest or is not fully informed. But it is building, systematically and with accelerating momentum, an alternative path for producing the materials and fuels that modern civilization depends on — a path that draws on renewable biological feedstocks instead of finite fossil carbon, that produces products capable of returning gracefully to biological cycles rather than persisting in the environment for centuries, and that operates through the elegant molecular machinery of life rather than the brute-force chemistry of high-temperature, high-pressure industrial synthesis.

Frequently Asked Questions

See More

Jude

Henry Jude writes about biotechnology and housing technology, focusing on the latest trends. He has 15 years of experience reporting on and analyzing advances in these fields. Holding both a BSc and an MSc in Biotechnology, he uses his scientific training to explain complex ideas clearly and show how new technologies can be applied in real life.